Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

In vivo expansion of a CD9 ⁺ decidual-like NK cell subset following autologous hematopoietic stem cell transplantation.

Autor: Orrantia A; Immunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain., Vázquez-De Luis E; Genomics Unit, Spanish National Center for Cardiovascular Research (CNIC), 28029 Madrid, Spain., Astarloa-Pando G; Immunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain., Terrén I; Immunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain., Amarilla-Irusta A; Immunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain., Polanco-Alonso D; Immunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain., González C; Biodonostia Health Research Institute, Hematology and Hemotherapy Service, Donostia University Hospital, 20014 Donostia-San Sebastián, Spain., Uranga A; Biodonostia Health Research Institute, Hematology and Hemotherapy Service, Donostia University Hospital, 20014 Donostia-San Sebastián, Spain., Carrascosa T; Hematological Cancer Group, Biocruces Bizkaia Health Research Institute, Hematology and Hemotherapy Service, Galdakao-Usansolo University Hospital, 48960 Galdakao, Spain., Mateos-Mazón JJ; Hematological Cancer Group, Biocruces Bizkaia Health Research Institute, Hematology and Hemotherapy Service, Cruces University Hospital, 48903 Barakaldo, Spain., García-Ruiz JC; Hematological Cancer Group, Biocruces Bizkaia Health Research Institute, Hematology and Hemotherapy Service, Cruces University Hospital, 48903 Barakaldo, Spain., Callejas S; Genomics Unit, Spanish National Center for Cardiovascular Research (CNIC), 28029 Madrid, Spain., Quintas A; Genomics Unit, Spanish National Center for Cardiovascular Research (CNIC), 28029 Madrid, Spain., Dopazo A; Genomics Unit, Spanish National Center for Cardiovascular Research (CNIC), 28029 Madrid, Spain.; CIBER de Enfermedades Cardiovasculares (CIBERCV), Madrid, Spain., Zenarruzabeitia O; Immunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain., Borrego F; Immunopathology Group, Biocruces Bizkaia Health Research Institute, 48903 Barakaldo, Spain.; Ikerbasque, Basque Foundation for Science, 48013 Bilbao, Spain.

Publikováno v: IScience [iScience] 2022 Sep 28; Vol. 25 (10), pp. 105235. Date of Electronic Publication: 2022 Sep 28 (Print Publication: 2022).

NK Cell Reconstitution After Autologous Hematopoietic Stem Cell Transplantation: Association Between NK Cell Maturation Stage and Outcome in Multiple Myeloma.

Autor: Orrantia A; Immunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain., Terrén I; Immunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain., Astarloa-Pando G; Immunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain., González C; Biodonostia Health Research Institute, Hematology and Hemotherapy Service, Donostia University Hospital, Donostia-San Sebastián, Spain., Uranga A; Biodonostia Health Research Institute, Hematology and Hemotherapy Service, Donostia University Hospital, Donostia-San Sebastián, Spain., Mateos-Mazón JJ; Hematological Cancer Group, Biocruces Bizkaia Health Research Institute, Hematology and Hemotherapy Service, Cruces University Hospital, Barakaldo, Spain., García-Ruiz JC; Hematological Cancer Group, Biocruces Bizkaia Health Research Institute, Hematology and Hemotherapy Service, Cruces University Hospital, Barakaldo, Spain., Riñón M; Regulation of the Immune System Group, Biocruces Bizkaia Health Research Institute, Immunology Service, Cruces University Hospital, Barakaldo, Spain., Rey M; Biodonostia Health Research Institute, Immunology Service, Donostia University Hospital, Donostia-San Sebastián, Spain., Pérez-Fernandez S; Scientific Coordination Facility, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain., Zenarruzabeitia O; Immunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain., Borrego F; Immunopathology Group, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.; Ikerbasque, Basque Foundation for Science, Bilbao, Spain.

Publikováno v: Frontiers in immunology [Front Immunol] 2021 Oct 05; Vol. 12, pp. 748207. Date of Electronic Publication: 2021 Oct 05 (Print Publication: 2021).

Clinical characteristics and outcome of SARS-CoV-2 infection in admitted patients with chronic lymphocytic leukemia from a single European country.

Autor: Muntañola A; Hospital Universitari Mútua Terrassa, Barcelona, Spain., Villacampa G; Oncology Data Science, Vall D'Hebron Institute of Oncology, Barcelona, Spain.; SOLTI Breast Cancer Research Group, Barcelona, Spain., Hernández-Rivas JÁ; Hospital Universitario Infanta Leonor, Madrid, Spain., Alonso R; Hospital Universitario Puerta de Hierro, Madrid, Spain., Mirás F; Hospital Universitario 12 de Octubre, Madrid, Spain., Osorio S; Hospital Universitario Gregorio Marañón/Gregorio Marañón Health Institute (IiSGM), Madrid, Spain., Baile M; Hospital Universitario de Salamanca/IBSAL, CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain., Baltasar P; Hospital Universitario La Paz, Madrid, Spain., López Jiménez J; Hospital Universitario Ramón y Cajal, Madrid, Spain., Hernandez-Rodriguez I; Hospital Germans Trias i Pujol-ICO Badalona, Barcelona, Spain., Valenciano S; Hospital Universitario Príncipe de Asturias, Madrid, Spain., Alfayate A; Hospital Clínico San Carlos, Madrid, Spain., Gimeno E; Hospital del Mar, Barcelona, Spain., Bárez A; Complejo Asistencial de Ávila, Ávila, Spain., Oliveira AC; Hospital Duran i Reynals-ICO Hospitalet, Barcelona, Spain., Riaza R; Hospital Universitario Severo Ochoa, Madrid, Spain., Romero P; Hospital Universitario Donostia, San Sebastián, Spain., Delgado J; Hospital Clínic de Barcelona, Barcelona, Spain., Yáñez L; Hospital Universitario Marqués de Valdecilla, Santander, Spain., Zabalza A; Complejo Hospitalario de Navarra, Pamplona, Spain., Torres A; Complejo Asistencial de Segovia, Segovia, Spain., Gómez-Roncero MI; Hospital Virgen de la Salud, Toledo, Spain., Crespo M; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain., Córdoba R; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Mateos-Mazón JJ; Hospital Universitario de Cruces, Barakaldo, Spain., Pérez S; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Andreu R; Hospital Universitario La Fe de Valencia, Valencia, Spain., Labrador J; Hospital Universitario de Burgos, Burgos, Spain., Ruiz ME; Hospital Universitario del Tajo, Madrid, Spain., Velasquez CA; Hospital de Mollet, Barcelona, Spain., Terol MJ; Hospital Clínico Universitario de Valencia, Valencia, Spain., Santiago R; Hospital Sant Joan de Déu de Manresa - Fundació ALTHAIA, Barcelona, Spain., Vidal MJ; Hospital Universitario de León, León, Spain., Campoy García F; Complexo Hospitalario Universitario de Ourense, Ourense, Spain., Villalón L; Hospital Universitario Fundación Alcorcón, Madrid, Spain., Muiña BS; Hospital Rafael Méndez de Lorca, Murcia, Spain., Soler JA; Consorci Corporació Sanitària Parc Taulí de Sabadell, Barcelona, Spain., Seri C; Hospital Central de la Defensa Gómez Ulla, Madrid, Spain., Sánchez MJ; Hospital Universitario Lucus Augusti, Lugo, Spain., Cuesta A; Hospital Sierrallana (Torrelavega), Cantabria, Spain., Ramos R; Hospital Universitario de Badajoz, Badajoz, Spain., Sánchez-Montalvá A; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain., Ruiz-Camps I; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain., González M; Hospital Universitario de Salamanca/IBSAL, CIBERONC and Center for Cancer Research-IBMCC (USAL-CSIC), Salamanca, Spain., Abrisqueta P; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain. pabrisqueta@vhio.net., Bosch F; Department of Hematology, Vall d'Hebron Barcelona Hospital Campus, Passeig de la Vall d'Hebron, 119-129, 08035, Barcelona, Spain.

Publikováno v: Experimental hematology & oncology [Exp Hematol Oncol] 2020 Dec 18; Vol. 9 (1), pp. 37. Date of Electronic Publication: 2020 Dec 18.

Complete remission of subcutaneous panniculitic T-cell lymphoma after allogeneic transplantation.

Autor: Pérez-Persona E, Mateos-Mazón JJ, López-Villar O, Arcos MJ, Encinas C, Graciani IF, Ocio EM, Sánchez-Guijo FM, Caballero MD

Publikováno v: Bone marrow transplantation [Bone Marrow Transplant] 2006 Dec; Vol. 38 (12), pp. 821-2. Date of Electronic Publication: 2006 Oct 23.